tiprankstipranks

Robin L. Smith Insider Profile

11 Followers
Robin L. Smith, Executive Chair of the Board, Director at Lisata Therapeutics, holds 236.07K shares in Celularity (Ticker: CELU), holds 235.00K shares in Sorrento Therapeutics (Ticker: SRNEQ), holds 167.97K shares in ServiceSource International (Ticker: SREV).
tipranks
Robin L. Smith

Robin L. Smith
Lisata Therapeutics (LSTA)
Executive Chair of the Board, Director

Ranked #15,472 out of 97,825 Corporate Insiders

Profitable Transactions

25%
1 out of 4 Profitable Transactions

Average Return

+34.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$3M
45.50%
44.17%
7.17%
2.01%
1.15% Others
A breakdown of Robin L. Smith's holdings

Insider Roles

Celularity
(CELU)
Director
Lisata Therapeutics
(LSTA)
Executive Chair of the Board, Director
Viridian Therapeutics
(VRDN)
Director
Rockwell Med
(RMTI)
Director
+3 other positions
Roles that Robin L. Smith holds in companies

Most Profitable Insider Trade

Stock:
Sorrento Therapeutics
(SRNEQ)
Rating:Informative Buy
Date:Mar 05, 2020 - Mar 05, 2021
Return:+282.70%
The most profitable trade made by Robin L. Smith

Robin L. Smith's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Lisata Therapeutics
Jun 04, 2015
Executive Chair of the Board, Director
Uninformative Buy
$1.13M
Rockwell Med
Jun 10, 2019
Director
Uninformative Buy
$51.44K
Emmaus Life Sciences
May 10, 2019
Director
Uninformative Buy
59.50K
$24.75K
Seelos Therapeutics
Director
Sorrento Therapeutics
Sep 03, 2021
Director
Informative Buy
785.25K
$4.70K
SREV
ServiceSource International
May 21, 2020
Informative Buy
85.00K
$251.96K
Celularity
Jun 16, 2023
Director
Uninformative Buy
$1.17M
Viridian Therapeutics
Feb 07, 2017
Director
Informative Buy
9.18K
$183.85K
List of latest transactions for each holding click on a transaction to see Robin L. Smith's performance on stock

Robin L. Smith insider profile FAQ

What is the percentage of profitable transactions made by Robin L. Smith?
The percentage of profitable transactions made by Robin L. Smith is 25%.
    What is the average return per transaction made by Robin L. Smith?
    The average return per transaction made by Robin L. Smith is 34.00%.
      What stocks does Robin L. Smith hold?
      Robin L. Smith holds: LSTA, RMTI, EMMA, SEEL, SRNEQ, SREV, CELU, VRDN stocks.
        What was Robin L. Smith’s latest transaction?
        Robin L. Smith latest transaction was an Uninformative Buy of ―.
          What was Robin L. Smith's most profitable transaction?
          Robin L. Smith’s most profitable transaction was an Informative Buy of SRNEQ stock on March 5, 2020. The return on the trade was 282.70%.
            What is Robin L. Smith's role in Lisata Therapeutics?
            Robin L. Smith's role in Lisata Therapeutics is Executive Chair of the Board, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.